Dr. Steven Craig Kester, MD

Dr. Kester practices at Urology Center of Florida PA in Pompano Beach, Florida.

Dr. Kester's NPI, 1033265723, was assigned on January 26, 2007. Dr. Kester graduated from University of Toledo College of Medicine and Life Sciences in 1985. Dr. Kester holds Florida license ME59998.

Dr. Kester's primary practice is Urology Center of Florida PA, at 550 SW 3rd St, Pompano Beach, FL 33060 in Broward County. The practice phone is (954) 941-3333.

Dr. Kester's primary practice is Urology Center of Florida PA in Pompano Beach, Florida. Dr. Kester is also affiliated with Holy Cross Health. The medical group on file is Urology Center of South Florida. Dmand AI also links Dr. Kester to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kester practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kester's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Kester's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, prostate cancer, testicular dysfunction and urinary endoscopy among the conditions Dr. Kester treats.

CMS data shows 50,292 Medicare services from Dr. Kester across 30 procedure codes in 2024, for 362 Medicare patients. Medicare paid $258,442 for them. Every service was in an office.

CMS counts 362 Medicare patients who saw Dr. Kester in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kester's median patient age at 66, with 11% women.

In 2024, Dr. Kester wrote 1,791 Medicare Part D claims for 433 patients. 97% of them were for generic drugs. CMS names the drug for 1,669 of them, across 22 drugs with 11 or more claims each, at $50,499 in total drug cost. In 2023, CMS named 1,516 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Kester for performance year 2024, reported as part of a group. Dr. Kester accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Kester in 2021. Dr. Kester's most frequent co-authors are Karim Chamie, MD, Lawrence I. Karsh, MD and Max R. Kates, MD.

Dmand AI links Dr. Kester to 6 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms, Prostatic Neoplasms and Urinary Bladder, Neurogenic. ImmunityBio, Inc. sponsors the most, 2.

CMS Open Payments shows 239 general payments to Dr. Kester from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Endo Pharmaceuticals Inc. paid the most, $819.

Dr. Kester graduated from University of Toledo College of Medicine and Life Sciences in 1985.

Dr. Kester is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.